The Hidden Costs of Cost Containment
Pharma teams everywhere are under pressure to do more with less. When budgets tighten, it’s tempting to opt for the lowest-cost technology or to build an internal solution. But as the old saying goes, what you see above the waterline is only part of the story.
As our virtual advisory board clients know well, “Most tools only address part of the challenge, leaving hidden costs, manual work, and data gaps below the surface.” Those invisible inefficiencies—moderation, transcription, reporting, data integration—add up fast. “Clients using Within3 save up to $10,000 per virtual session by consolidating capabilities that other vendors charge extra for or leave your team to manage manually.”
That same dynamic applies across the insight ecosystem of analytics, insights reporting, and launch performance tracking. What looks cheaper on paper can become more expensive over time, buried beneath inefficiencies that drag down speed, quality, and collaboration. Everything that’s built or bought has to work efficiently together to address all key needs, and the integrated system has to be sustainable across the launch timeline.
The Development Cliff
Internal builds provide classic examples of hidden costs. They start with good intentions—use existing data, develop proprietary tools, and keep spending in check. But internal platforms rarely survive the test of time for reasons that seem obvious when you stop to think about it.
Technology moves faster than most internal development timelines. As Tony Page, Expert Insights Consultant, MAPS Insights Competency Co-Lead, & Former Intelligence Officer, explained: “If technology is advancing faster than your development timeline, then it’s a questionable proposition to begin with. And when you factor in the costs of trying to keep up with advances, then it starts to be even more questionable.” Internal investments grow into expensive cost centers that then become targets for well-intentioned cost-cutting. The inevitability of internal reorganizations ensures these centers will be considered for cost-cutting.
Every reorganization resets priorities and funding. The teams that built the solution move on, and new leaders bring new objectives. What once looked like an efficient in-house platform falls behind technologically and becomes a maintenance burden—costly to update, fragile to scale, and disconnected from evolving needs.
That reality isn’t lost on industry peers. During a MAPS roundtable discussion, one participant summed it up bluntly: “Even something you started doing two years ago is already obsolete.”
The shelf life on internal builds is finite and often short. “The company timeline can be 24 months to build a solution, which may well mean it’s obsolete by the time it’s built. And enterprise solutions often don’t meet the needs of a product team anyway,” Page noted. “They’re going to be launched in 24 months but because there’s momentum behind building an internal solution, there’s a reluctance to spend money to buy a solution even though it can be ready in six weeks, and can solve 90% of their problems.”
That same hesitation came up during the MAPS discussion, where another participant observed: “If the tech is changing faster than your ability to develop, then developing makes no sense.”
Internal tools can absolutely deliver value—particularly for data storage, CRM, or compliance workflows. But without continuous innovation and integration, they eventually lag behind. That’s where Launch Intelligence™ bridges the gap.
Build + Buy
The question isn’t whether internal tools have value—they do. But there’s also value in buying tools that solve specific problems and offer certainty that the technology will not become outdated or become unavailable after the next reorg. Unlike pharma companies, tech companies are in the tech business, and they exist to build profit centers, not cost centers. A company that lives off their technology can innovate, invest, and build without having to fight other stakeholders for budget and without having to get compliance approval for every new initiative. Tech companies also often focus on specific business problems and scale that solution across multiple clients. The dynamic is completely different, ensuring that small tech companies will always out-innovate larger, more diversified businesses like pharma companies.
This is why many organizations today are shifting from a build vs. buy mindset to a build + buy model.
An ideal Launch Intelligence™ infrastructure complements what teams have already built by integrating seamlessly with existing data lakes, CRM systems, field analytics, and real-world evidence. It connects existing tools and fills in gaps to deliver insights that drive action.
Whether teams have partial frameworks or full-scale internal builds, Launch Intelligence™ amplifies internal efforts and other tools rather than replacing them. It provides the real-time layer that turns scattered systems into a single, intelligent launch infrastructure—one that keeps pace with the market instead of lagging behind it.
Smarter Investment, Sustainable Growth
Short-term savings—whether from cheaper vendors or DIY builds—can erode long-term performance. Sustainable advantage comes from reducing inefficiency, not just cutting cost.
Don’t cut costs. Cut inefficiencies.
In a market where launches peak faster and competition never sleeps, sustainability beats short-term savings. The smartest tech investment is one that delivers value across the launch timeline and ensures that all your other investments don’t disappear into the dark depths of a failed launch.
Talk to our experts about cutting inefficiencies, not corners, with Launch Intelligence™.
